Skeletal myopathy associated with nucleoside reverse transcriptase inhibitor therapy: Potential benefit of coenzyme Q 10 therapy

International Journal of STD and AIDS

Volumn 16, Issue 12, 2005, Pages 827-829

  Rosenfeldt, Franklin L ^a   Mijch, Anne ^a   McCrystal, Graham ^a   Sweeney, Clare ^a   Pepe, Salvatore ^a   Nicholls, Melissa ^a   Dennett, Xenia ^b  

^a ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Coenzyme Q 10; HIV; Skeletal myopathy; Zidovudine

Indexed keywords

RNA DIRECTED DNA POLYMERASE INHIBITOR; UBIDECARENONE; ZIDOVUDINE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COURSE EVALUATION; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISEASE COURSE; ELECTROMYOGRAPHY; ELECTRON MICROSCOPY; GENERAL CONDITION IMPROVEMENT; HUMAN; LABORATORY TEST; MALE; MEDICAL EXAMINATION; MITOCHONDRIAL MYOPATHY; MUSCLE BIOPSY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; DRUG THERAPY, COMBINATION; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DISEASES; REVERSE TRANSCRIPTASE INHIBITORS; TREATMENT OUTCOME; UBIQUINONE; ZIDOVUDINE;

EID: 30944447281     PISSN: 09564624     EISSN: 09564624     Source Type: Journal    
DOI: 10.1258/095646205774988127     Document Type: Article

References (8)

1. Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL. Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 1990;322:1098-105
2. Linnane AW, Degli Esposti M, Generowicz M, et al. The universality of bioenergetic disease and amelioration with redox therapy. Biochim Biophys Acta 1995;1271:191-4
3. Dalakas MG. Retrovirus-related muscle disease. In Engel AG, Franzine - Armstrong C, eds. Myology. 2nd Edn. 1994; Ch 54, 1419-37
4. Masini A, Scotti C, Calligaro A, et al. Zidovudine-induced experimental myopathy: dual mechanism of mitochondrial damage. J Neurol Sci 1999;166:131-40
5. Lane RJ, McLean KA, Moss J, Woodrow DF. Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions. Neuropathy Appl Neurobiol 1993;19:406-13
6. Carr A, Workman C, Smith DE, et al., Mitochondrial Toxicity (MITOX) Study Group. Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial. JAMA 2002;288:207-15
7. 10 as an adjunctive in the treatment of chronic congestive heart failure. J Cardiac Failure 1995;1:101-7
8. 10 in HIV infection and exploratory treatment. Biochem Biophys Res Commun 1988;153:888-96